In vitrocombinations of natamycin with voriconazole, itraconazole and micafungin against clinicalFusariumstrains causing keratitis: Table 1. | Zendy

Abdullah M. S. AlHatmi | Zendy; Joseph Meletiadis | Zendy; Ilse Curfs-Breuker | Zendy; Alexandro Bonifáz | Zendy; Jacques F. Meis | Zendy; Sybren de Hoog | Zendy

Open Access

In vitrocombinations of natamycin with voriconazole, itraconazole and micafungin against clinicalFusariumstrains causing keratitis: Table 1.

Author(s) -

Abdullah M. S. AlHatmi,

Joseph Meletiadis,

Ilse Curfs-Breuker,

Alexandro Bonifáz,

Jacques F. Meis,

Sybren de Hoog

Publication year - 2015

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkv421

Subject(s) - natamycin , voriconazole , micafungin , itraconazole , microbiology and biotechnology , antifungal , fusarium , in vitro , biology , fusarium solani , fungal keratitis , keratitis , medicine , dermatology , botany , pathology , biochemistry

Fusarium species cause a broad spectrum of infections, from superficial to disseminated disease. Because Fusarium species are intrinsically resistant to most antifungal drugs, new approaches are needed. The aim of the present study was to evaluate the in vitro combination of natamycin with currently used antifungal drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research